Applications are now open for the 2025 ABHI US Accelerator. This unique 12-month programme is designed to support UK medical device, diagnostic, and digital health companies in entering the US market.
Now in its eighth year, the ABHI US Accelerator helps companies define their US strategy, de-risk market entry, and grow their business through ABHI’s expertise and connections. Past participants have reported impressive outcomes, with contract wins ranging from $250,000 to $60 million, and an average expected business generation of $15 million over five years due to their involvement in the programme.
As a member you gain access to:
- Over 330 clinicians and senior leaders at 35+ hospitals and 25+ academic systems.
- GPOs, insurers, investors, and more key stakeholders to support your US journey.
- Expert guidance to navigate regulatory pathways, market access, and reimbursement challenges.
- A wide-reaching mentor network with industry experts to help you navigate the US healthcare landscape.
- Year-round trade missions and virtual activities tailored to enhance your presence in the US.
This programme provides a valuable opportunity to meet directly with decision-makers and understand the needs of end users in the US healthcare system. By leveraging ABHI’s strong network, companies can build relationships that are crucial for successful market entry and scaling up in the US.
In the words of past member Nick De Pennington, Founder & CEO of Ufonia, “It has been quite amazing to have a level of access and engagement from the senior leadership teams of some of the largest healthcare organisations within the US. The ABHI US Accelerator opportunity has been invaluable for our company, allowing us to make connections and understand the needs of end users and decision makers, so that we can effectively deploy and scale-up our business in the US market.”
Interested in learning more? Sign up for our webinar on 3rd December 2024, 15:00 - 16:30 or write to me at sophie.green@abhi.org.uk.
Apply now – spaces are limited and applications close on 10th January 2025.
